| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |